Vendor strategies in the global contrast injectors market

The global contrast injectors market is expected to grow at a CAGR of 5.55% during the forecast period. Major vendors in the global contrast injectors market include Bayer AG, Bracco Spa, General Electric Co., Guerbet, MEDTRON AG, Nemoto Kyorindo Co. Ltd., Shenzhen Anke High-tech Co. Ltd., Shenzhen Seacrown Electromechanical Co. Ltd., Sino Medical-Device Technology Co. Ltd., and ulrich GmbH & Co. KG.

Vendors are focusing on various strategies such as M&A and partnerships to expand their market reach. For instance, Bayer AG, in October 2019, the company announced that it had signed collaboration agreements with 11 digital health start-ups under its G4A Digital Health Partnerships program. Bracco Spa, in June 2019, the company announced that it had signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company based in Oxford, UK.

Request for: Free Sample Report

Similarly, General Electric Co., in December 2019, the company announced that it would enter into a strategic R&D and distribution partnership with Advanced Solutions Life Sciences (ASLS) to create new opportunities for regenerative tissue manufacturing. Guerbet, in October 2019, the company announced that it had signed an exclusive agreement with icometrix for the distribution in France, Italy, and Brazil of icobrain, their Saas (Software as a Service) artificial intelligence-based medical imaging solution. Hence, the growing number of M&A and partnerships among vendors is expected to propel the growth of the global contrast injectors market during the forecast period.